ORAGENICS, INC. Liabilities Assumed
ORAGENICS, INC. (OGEN) reported Liabilities Assumed of $49.40 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2016-08-15
- ORAGENICS, INC. liabilities assumed for the quarter ending 2016-06-30 was $0.00.
- ORAGENICS, INC. liabilities assumed for the quarter ending 2016-03-31 was $49.40K, a 0.00% change year-over-year.
- ORAGENICS, INC. liabilities assumed for the quarter ending 2015-12-31 was $0.00.
- ORAGENICS, INC. liabilities assumed for the quarter ending 2015-09-30 was $109.07K, a 0.70% increase year-over-year.
- ORAGENICS, INC. liabilities assumed for fiscal 2015 was $158.46K, a 0.34% decline from fiscal 2014.
- ORAGENICS, INC. liabilities assumed for fiscal 2014 was $159.00K, a 1.27% increase from fiscal 2013.
- ORAGENICS, INC. liabilities assumed for fiscal 2013 was $157.00K, a 16.37% increase from fiscal 2012.
- ORAGENICS, INC. liabilities assumed for fiscal 2012 was $134.91K, a 6.45% increase from fiscal 2011.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $49.40K 10-Q · filed 2016-08-15 | $49.40K derived: sum of 3 quarters · filed 2016-08-15 | $158.46K derived: sum of 4 quarters · filed 2016-08-15 |
| 2016-03-31 | $49.40K 10-Q · filed 2016-05-16 | $49.40K derived: sum of 2 quarters · filed 2016-05-16 | $158.46K derived: sum of 3 quarters · filed 2016-05-16 | $158.46K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $109.07K derived: sum of 2 quarters · filed 2016-03-30 | $109.07K derived: sum of 3 quarters · filed 2016-08-15 | $158.46K 10-K · filed 2016-03-30 |
| 2015-09-30 | $109.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $109.07K derived: sum of 2 quarters · filed 2016-08-15 | $158.46K 10-Q · filed 2015-11-06 | $158.46K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $49.40K 10-Q · filed 2016-08-15 | $49.40K derived: sum of 3 quarters · filed 2016-08-15 | $157.70K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | $49.40K 10-Q · filed 2016-05-16 | $49.40K derived: sum of 2 quarters · filed 2016-05-16 | $157.70K derived: sum of 3 quarters · filed 2016-05-16 | $157.70K derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $108.31K derived: sum of 2 quarters · filed 2016-03-30 | $108.31K derived: sum of 3 quarters · filed 2016-03-30 | $159.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | $108.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $108.31K derived: sum of 2 quarters · filed 2015-11-06 | $159.00K 10-Q · filed 2015-11-06 | $158.97K derived: sum of 4 quarters · filed 2015-11-06 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $50.69K 10-Q · filed 2015-08-07 | $50.67K derived: sum of 3 quarters · filed 2015-08-07 | $50.67K derived: sum of 4 quarters · filed 2015-08-07 |
| 2014-03-31 | $50.69K 10-Q · filed 2015-05-08 | $50.67K derived: sum of 2 quarters · filed 2015-05-08 | $50.67K derived: sum of 3 quarters · filed 2015-05-08 | $157.66K derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | -$26.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$26.00 derived: sum of 2 quarters · filed 2015-02-27 | $106.97K derived: sum of 3 quarters · filed 2015-02-27 | $157.00K 10-K · filed 2015-02-27 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $106.99K derived: sum of 2 quarters · filed 2014-11-03 | $157.03K 10-Q · filed 2014-11-03 | $157.03K derived: sum of 4 quarters · filed 2014-11-03 |
| 2013-06-30 | $106.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $157.03K 10-Q · filed 2014-08-07 | $157.03K derived: sum of 3 quarters · filed 2014-08-07 | $241.91K derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | $50.04K 10-Q · filed 2014-05-09 | $50.04K derived: sum of 2 quarters · filed 2014-05-09 | $134.91K derived: sum of 3 quarters · filed 2014-05-09 | $134.91K derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $84.88K derived: sum of 2 quarters · filed 2014-02-28 | $84.88K derived: sum of 3 quarters · filed 2014-02-28 | $134.91K 10-K · filed 2014-02-28 |
| 2012-09-30 | $84.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25 | $84.88K derived: sum of 2 quarters · filed 2013-10-25 | $134.91K 10-Q · filed 2013-10-25 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $50.04K 10-Q · filed 2013-08-12 | ||
| 2012-03-31 | $50.04K 10-Q · filed 2013-05-15 | |||
| 2011-12-31 | $126.74K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |